https://www.yalemedicine.org/clinical-trials/a-phase-3-randomized-trial-of-inotuzumab-ozogamicin-ind133494-nsc-772518-for-newly-diagnosed
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia...